Syncom Formulations (India) Limited

Syncom Formulations (India) Limited (SYNCOMF) is a micro-cap Healthcare company valued at ₹2,060 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Syncom Formulations (India) Limited last traded at ₹22.01, up 2.09% on the day.

Recent developments

On 2026-09-23, the company announced a dividend of ₹0.10 per share, with the ex-date set for that date.

Financial performance

The company's annual revenue rose 6.1% year-over-year, while annual net profit surged 56.0%. In the latest quarter, revenue increased 7.3% compared to the same quarter a year earlier, and net profit jumped 55.3%.

Valuation multiples

The stock trades at 27.2 times earnings, a discount to the Healthcare median of 32.0, 5.43 times book value. It yields 0.5%.

Things to watch

The company's return on equity is 0.0%, which indicates no return to shareholders. The stock is 12.8% below its 52-week high.

Where it stands

The company has shown strong growth in both revenue and net profit over the past three and five years. The latest quarter saw significant increases in both revenue and net profit compared to the same quarter a year earlier. The stock is currently 12.8% below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.